Montgomery v Lanarkshire Health Board [2015] UKSC 11

Montgomery v Lanarkshire Health Board [2015] UKSC 11: Case Summary

Montgomery (Appellant) v Lanarkshire Health Board [2015] UKSC 11; [2015] AC 1430, decision by Supreme Court of the United Kingdom (Seven-Justice Bench), decided on 11 March 2015.

Introduction:

Montgomery v Lanarkshire Health Board [2015] UKSC 11 marks a significant case in medical negligence law.[1] This case refers to a doctor’s obligation to seek informed consent before a treatment takes place. The Supreme Court considered whether doctors had an obligation to inform patients of potential risks and suitable alternatives. Before this case, the Bolam test primarily relied on professional medical opinion to determine disclosures.[2] The Court rejected this approach in consent cases. Rather, a patient-centred standard was introduced. The court recognised that competent individuals have the right to make educated choices regarding their own medical care. Patient autonomy was reinforced by the ruling. Additionally, it changed informed consent legislation across the United Kingdom. Montgomery remains as one of the foremost authorities on medical negligence.

Facts of the Case:

The appellant was a woman named Nadine Montgomery. Throughout her pregnancy, she experienced diabetes. She had a higher chance of having a larger baby compared to average due to her diabetes. She was likely to have shoulder dystocia during vaginal birth. Shoulder dystocia occurs when a baby’s shoulders become stuck after the head is delivered. Both the mother and the kid could suffer severe harm as a result of this complication.

Dr. Linda McLellan, a consultant obstetrician working for Lanarkshire Health Board provided antenatal care to Mrs. Montgomery. Dr. McLellan was aware that moms with diabetes were more likely to experience shoulder dystocia. She calculated the danger to be between 9 and 10%. Additionally, she was aware that this specific risk could be avoided with an elective cesarean section.

Mrs. Montgomery was not informed by Dr. McLelllan about the risk of shoulder dystocia. Furthermore, she did not address the possibility of an elective cesarean section. She believed that if women were aware of the risks, they would request cesarean births. She believed if women were aware of the risks, they would request cesarean deliveries. She argued that the risk was insufficient to justify routinely informing patients unless they specifically requested it.

Mrs. Montgomery carried out with the vaginal birth. While in labour, shoulder dystocia occurred. The baby was successfully delivered by the medical staff. Nevertheless, the baby experienced oxygen deprivation at time of birth. Additionally, he suffered with brachial plexus. These conditions led to cerebral palsy and permanent disabilities.

She claimed that if she had been aware of the risks and the alternatives, she would have chosen for an elective caesarean section. Mrs. Montgomery stated that the doctor’s inability to convey these risks prevented her from making an informed decision about her treatment.

Therefore, the case dealt with informed consent rather than medical care. The Supreme Court had to determine the extent of a doctor’s legal obligation to disclose risks before attaining the patients consent.

Legal Issues:

The Supreme Court had to rule on several types of legal concerns relating to a doctor’s obligation to get informed consent. The primary question was whether a patient’s right to make informed decisions regarding medical care was sufficiently protected by the current legislation for disclosure.

The Court examined the following issues:

• Issue 1: Should the Bolam test still govern to a doctor’s obligation to disclose material risks associated to medical treatment?[3]
• Issue 2: Did Mr. Linda McLellan violate her duty of care by neglecting to warn Mrs. Montgomery regarding the significant risk of shoulder dystocia that comes with vaginal delivery?
• Issue 3: Whether Dr McLellan had a responsibility to inform Mrs Montgomery of the reasonable alternative of an elective cesearen section.
• Issue 4: Whether the failure to disclose the substantial risk of shoulder dystocia and the reasonable alternative treatments denied Mrs. Montgomery the opportunity to make an informed decision concerning the method of delivery.

Arguments Presented:

Appellant’s Arguments:

According to Mrs. Montgomery, Dr. McLellan did not acquire informed consent. She believed that her pregnancy alongside diabetes increased her chances of experiencing shoulder dystocia. She claimed that a rational patient would have seen the risk as significant.

The appellant contended that the Bolam test should not dictate what information doctors are required to give their patients.[4] She argued that permission is about patients’ choice rather than medical insight. Therefore, patients must have sufficient information to decide whether to accept or refuse treatments.

The principles of patient autonomy and self- determination were presented by the appellant. She emphasized that both material risks and suitable alternative treatments were to be disclosed regarding these principles.

Respondent’s Arguments:

The Lanarkshire Health Board contended that Dr. McLellan’s actions were consistent with standard medical practices. The respondent relied on the Bolam Principle.[5] She implied that doctor should have professional discretion when determining which risks to discuss.

According to the respondent, unusual risk disclosure could lead to excessive anxiety. Her defence was that the risk was minimal. Additionally, she argued that decisions regarding the disclosure of information should remain a matter of professional medical expertise.

As a result, the respondent determined that the duty of care had not been violated.

Court’s Reasoning and Analysis:

The Supreme Court rejected governing the Bolam test to cases involving informed consent. The Court distinguished medical diagnosis and treatment from a duty to advise patients.[6] They claimed that treatment alternatives are made by the patient, rather than the doctors. The Court shifted away from the approach in Sidaway v Board of the Governors of the Bethlem Royal Hospital, which had been adapted a doctor-centred disclosure standard.[7]

According to the Court, doctors have a duty to ensure patients are aware of any material risks. Any appropriate alternative treatments should also be discussed.  A risk is considered material if it is likely to be significant to a reasonable person in the patient’s position. Additionally, a risk qualifies as material if the doctor is aware that the patient may consider it important.

The Court determined that there was a clear significant risk of shoulder dystocia. The risk was increased due to Mrs. Montgomery’s diabetes. Another alternative was an elective cesarean section. Therefore, Dr. McLellan was obligated to address both concerns.

Patient autonomy was recognized by the Court as a fundamental legal principle. Patients have the right to determine which risks they are willing to accept. Doctors should support this decision by providing appropriate information rather than assuming it on the patient’s behalf.

Judgment and Ratio Decidendi:

The appeal was unanimously granted by the Supreme Court. They ruled that Lanarkshire Health Board had breached its duty of care. Mrs. Montgomery was not given sufficient information to make an informed decision.

According to the ratio decidendi, doctors must take reasonable measures to guarantee that patients are informed of all material risks associated with the proposed treatment and any appropriate alternatives. The significance of the risk to the patient is what determines materiality, rather than professional medical expertise. This standard is not based on the opinion of medical professionals. It is determined by the patient’s perspective and requirements for making better judgements.

Th Court further stated that doctors are not obligated to disclose all potential risks. This duty id restricted to risks that are given significant given the patient’s particular condition or that a reasonable patient would consider relevant. 

This principle replaced the traditional doctor-centred approach with a patient-centred standard for informed consent. Therefore, the Bolam test is no longer applicable under informed consent cases.[8] The doctor and patient must now actively communicate any concerns. This verdict reinforced the principle of patient autonomy. This ruling is in accordance with further developments in informed consent laws such as Chester v Afshar, which improved patient autonomy in medical practices.[9]

Critical Analysis:

This ruling redefined the law of informed consent. It prioritized patient autonomy while achieving medical decisions. As a result, doctors must now communicate directly with patients instead of determining what information to withhold based on their own professional judgement.

Additionally, this decision limited the application of Bolam test in consent cases.[10] Medical opinion remains central in diagnosis and treatment. However, it no longer determines whether a doctor has disclosed sufficient information to obtain informed consent. Furthermore, the Court developed a patient-centred requirement that specifies doctors communicate material risks and any feasible alternative treatments that would be regarded significant by a reasonable patient. 

This ruling has provided patients with advanced legal protection. Furthermore, it assisted in improved communication between patients and healthcare professionals. Medical practitioners must now examine each patient’s specific circumstances and concerns before obtaining consent. This has resulted in changes in medical practice, with a stronger focus on effective communication and extensive discussion of alternative treatments.

Montgomery continues to have influence over negligence claims involving informed consent cases. The principles established by the Supreme Court have affected clinical practice and future judicial rulings. This case remains as a significant ruling in modern medical law and serves as a guide to courts in determining whether proper informed consent has been obtained.

Conclusion:

The United Kingdom’s informed consent laws were altered by Montgomery v. Lanarkshire Health Board. The Supreme Court ruled that patients have the right to be informed about material risks and reasonable alternatives before determining their treatment.

This case created a patient-centred standard that prioritizes autonomy when exercising medical judgements. Courts and medical professional continue complying with these principles. Montgomery v Lanarkshire Health Board remains as a leading authority on informed consent, with its significant influence on medical negligence law.[11]

Bibliography

Tables of Cases:

1. Montgomery v Lanarkshire Health Board [2015] UKSC 11, [2015] AC 1430
2. Bolam v Friern Hospital Management Committee [1957] 1 WLR 582
3. Sidaway v Board of Governors of the Bethlem Royal Hospital [1985] AC 871
4. Chester v Afshar [2004] UKHL 41, [2005] 1 AC 134

[1] Montgomery v Lanarkshire Health Board [2015] UKSC 11, [2015] AC 1430.

[2] Bolam v Friern Hospital Management Committee [1957] 1 WLR 582.

[3] ibid.

[4] ibid.

[5] ibid.

[6] ibid.

[7] Sidaway v Board of Governors of the Bethlem Royal Hospital [1985] AC 871.

[8] ibid.

[9] Chester v Afshar [2004] UKHL 41, [2005] 1 AC 134.

[10] ibid.

[11] ibid.